TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.

scientific article

TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00280-008-0879-3
P698PubMed publication ID19052714

P50authorHo Young ChungQ89795559
P2093author name stringKi-Young Kwon
Kyung Hee Lee
Min Kyoung Kim
Myung Soo Hyun
Jong Gwang Kim
Sang Kyun Sohn
Wansik Yu
Yee Soo Chae
Hong Suk Song
Joo Seop Jung
Young Rok Do
Won Sik Lee
Gab Chul Kim
Chang-Hak Sohn
P2860cites workRandomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerQ33488159
Two polymorphic variants of wild-type p53 differ biochemically and biologicallyQ33868530
P433issue2
P921main subjectcisplatinQ412415
paclitaxelQ423762
P304page(s)355-360
P577publication date2008-12-04
P1433published inCancer Chemotherapy and PharmacologyQ326137
P1476titleTP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
P478volume64

Reverse relations

cites work (P2860)
Q38921842Aging, inflammation, immunity and periodontal disease
Q60955798Association of rs1042522 SNP with Clinicopathologic Factors of Breast Cancer Patients in the Markazi Province of Iran
Q34668730Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review).
Q37138359Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females
Q43509391Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy
Q50580742Effects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimen.
Q26741242Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature
Q37037859Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma
Q92840993GSTP1 exon 5 rs200139798 polymorphism and clinicopathological characteristics of gastric cancer in Chinese patients
Q52683821Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes.
Q27012898Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications
Q28068930Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use
Q34982250Prognostic role of apoptosis-related gene functional variants in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy
Q58050536TruSight Cancer Sequencing Panel reveals pharmacogenetic variants associated with sensitivity to chemotherapy in lung cancer

Search more.